Salvage prostate intensity modulated radiation therapy after cryotherapy failure.
Biochemical relapse
Cryoablation
Prostate cancer
Salvage radiotherapy
Toxicity
Journal
Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288
Informations de publication
Date de publication:
21 Apr 2024
21 Apr 2024
Historique:
received:
07
11
2023
accepted:
10
04
2024
medline:
22
4
2024
pubmed:
22
4
2024
entrez:
21
4
2024
Statut:
epublish
Résumé
Cryotherapy is an ablative therapy that can be used to treat localized prostate cancer. In case of recurrence, treatment options are not well-defined, and their outcomes are unknown. We therefore collected all patients treated with radiotherapy after cryotherapy for prostate cancer recurrence in Nantes (France) between 2012 and 2019. We identified ten patients. After a median follow-up of 5 years, two patients presented late grade 3 toxicities; one patient presented a grade 3 rectal hemorrhage, and one had a grade 3 hematuria. Two patients relapsed at 61 and 62 months, and three patients died of other causes. Radiotherapy to treat local prostate cancer recurrence after cryotherapy seems feasible and effective in local control. These results do not allow us to recommend this technique in current practice but are encouraging for the conduct of prospective trials.
Identifiants
pubmed: 38644367
doi: 10.1038/s41598-024-59406-8
pii: 10.1038/s41598-024-59406-8
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
9148Informations de copyright
© 2024. The Author(s).
Références
Baust, J. G. & Gage, A. A. The molecular basis of cryosurgery. BJU Int. 95(9), 1187–1191 (2005).
doi: 10.1111/j.1464-410X.2005.05502.x
pubmed: 15892798
Gage, A. A. & Baust, J. Mechanisms of tissue injury in cryosurgery. Cryobiology 37(3), 171–186 (1998).
doi: 10.1006/cryo.1998.2115
pubmed: 9787063
Langenhuijsen, J. F., Broers, E. M. P. & Vergunst, H. Cryosurgery for prostate cancer: an update on clinical results of modern cryotechnology. Eur Urol. 55(1), 76–86 (2009).
doi: 10.1016/j.eururo.2008.08.063
pubmed: 18789572
Mottet, N. et al. EAU-EANM-ESTRO-ESUR-SIOG Guidelines on Prostate Cancer-2020 Update. Part 1: Screening, Diagnosis, and Local Treatment with Curative Intent. Eur Urol. 79(2), 243–262 (2021).
doi: 10.1016/j.eururo.2020.09.042
pubmed: 33172724
Valle LF, Lehrer EJ, Markovic D, Elashoff D, Levin-Epstein R, Karnes RJ, et al. A Systematic Review and Meta-analysis of Local Salvage Therapies After Radiotherapy for Prostate Cancer (MASTER). Eur Urol. 2020 Dec 10
National Comprehensive Cancer Network. NCCN Prostate cancer guidelines (version 1.2023). 2023; Available from: nccn.org
Donnelly, B. J. et al. A randomized trial of external beam radiotherapy versus cryoablation in patients with localized prostate cancer. Cancer. 116(2), 323–330 (2010).
doi: 10.1002/cncr.24779
pubmed: 19937954
Long, J. P. et al. Five-year retrospective, multi-institutional pooled analysis of cancer-related outcomes after cryosurgical ablation of the prostate. Urology. 57(3), 518–523 (2001).
doi: 10.1016/S0090-4295(00)01060-8
pubmed: 11248631
Burton, S. et al. Salvage radiotherapy for prostate cancer recurrence after cryosurgical ablation. Urology. 56(5), 833–838 (2000).
doi: 10.1016/S0090-4295(00)00778-0
pubmed: 11068312
Jones, J. S. et al. Whole gland primary prostate cryoablation: initial results from the cryo on-line data registry. J Urol. 180(2), 554–558 (2008).
doi: 10.1016/j.juro.2008.04.027
pubmed: 18550117
McDonough, M. J., Feldmeier, J. J., Parsai, I., Dobelbower, R. R. & Selman, S. H. Salvage external beam radiotherapy for clinical failure after cryosurgery for prostate cancer. Int J Radiat Oncol Biol Phys. 51(3), 624–627 (2001).
doi: 10.1016/S0360-3016(01)01694-7
pubmed: 11597801
Lischalk, J. W. et al. Salvage prostate stereotactic body radiation therapy after definitive cryoablation. Advances in Radiation Oncology. 7(3), 100849 (2022).
doi: 10.1016/j.adro.2021.100849
pubmed: 35647408
Jiang, C. et al. Early comparative toxicity outcomes of patients with prostate cancer receiving initial cryotherapy and radiotherapy salvage. Clin Genitourin Cancer. 19(3), 267-270.e1 (2021).
doi: 10.1016/j.clgc.2020.03.007
pubmed: 33191148
Hopper, A. B., Sandhu, A. P. S., Parsons, J. K., Rose, B. & Einck, J. P. Salvage image guided radiation therapy to the prostate after cryotherapy failure. Adv Radiat Oncol. 3(1), 52–56 (2018).
doi: 10.1016/j.adro.2017.09.001
pubmed: 29556580
Choi, M., Kim, C. R. & Hung, A. Y. Salvage intensity-modulated radiation therapy for locally recurrent prostate cancer after cryotherapy. Clin Genitour Cancer 11(2), 85–88 (2013).
doi: 10.1016/j.clgc.2012.09.003
U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES, National Institutes of Health, National Cancer Institute. Common Terminology Criteria for Adverse Events (CTCAE) version 5.0. 2017
Roach, M. et al. Defining biochemical failure following radiotherapy with or without hormonal therapy in men with clinically localized prostate cancer: recommendations of the RTOG-ASTRO Phoenix Consensus Conference. Int J Radiat Oncol Biol Phys. 65(4), 965–974 (2006).
doi: 10.1016/j.ijrobp.2006.04.029
pubmed: 16798415
Rhee, H. et al. Adverse effects of androgen-deprivation therapy in prostate cancer and their management. BJU Int. 115(Suppl 5), 3–13 (2015).
doi: 10.1111/bju.12964
pubmed: 25327530
Rogé, M. et al. Salvage radiotherapy after initial cryotherapy for localized prostate cancer: a systematic review of the literature. Crit Rev Oncol Hematol. 7, 104149 (2023).
doi: 10.1016/j.critrevonc.2023.104149
Hamstra, D. A. et al. Age and comorbid illness are associated with late rectal toxicity following dose-escalated radiation therapy for prostate cancer. Int J Radiat Oncol Biol Phys. 85(5), 1246–1253 (2013).
doi: 10.1016/j.ijrobp.2012.10.042
pubmed: 23265567